Erectile disorder: How science is moving beyond Viagra
medicalxpress - Erectile disorder (ED) refers to a persistent difficulty achieving or maintaining an erection sufficient for satisfying sexual activity. It affects millions of men worldwide, including up to 1 in 4 in the United States. Beyond physical functioning, erecti…
AI Summary: Researchers are advancing alternatives to sildenafil-era approaches for erectile disorder, exploring new biological targets and therapies that aim to restore function rather than just patch symptoms. The coverage explains emerging mechanisms, investigational treatments and the shifting clinical landscape—because sometimes a Band-Aid on performance isn’t the long-term plan.
Related Stories
Mid‑stage Parkinson trial failure halts drug development plans / 3 months
Gene therapy pioneers win Breakthrough Prize for CRISPR sickle‑cell work / 4 months
New enzyme shows promise for clearing senescent 'zombie' cells / 5 wks
First-in-human trial primes immune system to accept donor livers / 4 months
Experimental therapy significantly reduces Parkinson’s toxic protein in early trial / 4 months
Keratin 16 restrains skin inflammation and may guide treatments / 4 months
Agenus halts BATTMAN trial, launches ROBBIN replacement / 5 wks
StackHealth RSS
You can now follow topics by RSS - browse the complete list of topics, people, and organizations. Or, try Corporate Takeover, Mergers and Acquisitions, Alzheimer's disease, Rural Health and look for the RSS link.
StackHealth Time Machine